ZERIA PHARMACEUTICAL CO.,LTD.

4559

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2027 Q1

Revenue

911.2100M JPY

YoY +6.8%

Operating Income

19.5100M JPY

YoY +28.3%

Net Income

82.3100M JPY

YoY +20.8%

EPS

19.6JPY

YoY -20.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

891.6億円

668.7億円

445.8億円

222.9億円

Rev: 595.3億円Op: 63.7億円NI: 39.6億円

Rev: 683.8億円Op: 90.1億円NI: 62億円

Rev: 757.3億円Op: 96.2億円NI: 77.3億円

Rev: 873.1億円Op: 122億円NI: 99.4億円

Rev: 891.6億円Op: 123.7億円NI: 84.5億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income8.7%

Revenue Progress214.500M

Revenue Forecast95000M

Net Income Progress8.700M

Net Income Forecast10000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan